epocrates logo
epocrates logo
epocrates logo
  • 0

Journal Article Synopsis

JAMA Surg

Encouraging long-term results for the first 50 face transplants

September 23, 2024

card-image

Face transplants have an encouraging long-term survival rate, making them a viable option for reconstructing extensive facial defects.

The study included the first 50 face transplant recipients worldwide, comprising 39 men (81%) and 9 women (19%), with a median age of 35 years. Median follow-up was 8.9 years.

During follow-up, 6 transplants were lost with 2 patients retransplanted. Ten patients died, 2 of whom had lost a transplant. The 5- and 10-year survival rates for the transplants were 85% and 74%, respectively. The sequential number of the transplant globally was a significant predictor of survival (hazard ratio, 95; 95% CI, 90-100; P < 05). The median number of acute rejection episodes per year was 1.2 for lost transplants and 0.7 for surviving transplants.

Source:

Homsy P, et al. (2024, September 18). JAMA Surg. An Update on the Survival of the First 50 Face Transplants Worldwide. https://pubmed.ncbi.nlm.nih.gov/39292472/

Trending icon

TRENDING THIS WEEK

EPOCRATES CME

View Catalog

view all CME activities
learn more about epocrates plus
Clinical FAQ icon

Clinical FAQs

Check out the answers to frequently asked questions about our clinical content.

Download Epocrates from the App StoreDownload Epocrates from the Play Store
About UsFeaturesBusiness SolutionsHelp & Feedback
© 2026 epocrates, Inc.   Terms of UsePrivacy PolicyEditorial PolicyDo Not Sell or Share My Information